Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Journal article published in 2024 by
Stephen J. Bagley 
,
Zev A. Binder ,
Lamia Lamrani,
Eliana Marinari,
Arati S. Desai,
MacLean P. Nasrallah ,
Eileen Maloney,
Steven Brem ,
Robert A. Lustig,
Goldie Kurtz,
Michelle Alonso-Basanta,
Pierre-Emmanuel Bonté ,
Christel Goudot,
Wilfrid Richer,
Eliane Piaggio
and other authors.
,
Zev A. Binder ,
Lamia Lamrani,
Eliana Marinari,
Arati S. Desai,
MacLean P. Nasrallah ,
Eileen Maloney,
Steven Brem ,
Robert A. Lustig,
Goldie Kurtz,
Michelle Alonso-Basanta,
Pierre-Emmanuel Bonté ,
Christel Goudot,
Wilfrid Richer,
Eliane Piaggio
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 